In January of this year, the FDA noted that it had "received adverse event reports after patients used compounded semaglutide" and that "patients should not use a compounded drug if an approved drug is available to treat a patient." In July, the agency followed up with a notice that it had "received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products." And in August, Eli Lilly, the maker of Zepbound and Mounjaro, sent a series of cease-and-desist letters to providers urging them to stop prescribing compounded versions of those drugs
Approved for Obesity: Wegovy (semaglutide ) : Approved specifically for chronic weight management in adults with obesity or overweight conditions, alongside dietary and exercise changes
Food just stopped being this constant background noise in my head
Considering the significantly elevated expression levels of GLP-1R in diabetic patients, it is hypothesized that administration of GLP-1R agonists may elevate the risk of breast cancer progression in these patients, thus necessitating particular caution in clinical management [101]
Want to enhance their body's natural detoxification and metabolic processes
Its purpose is to align medication preparation with individualized treatment planning